Russell Investments Group’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,057
| Closed | -$9.25K | – | 3859 |
|
|
2024
Q4 | $9.25K | Buy |
5,057
+148
| +3% | +$271 | ﹤0.01% | 3154 |
|
|
2024
Q3 | $8.35K | Sell |
4,909
-114,613
| -96% | -$195K | ﹤0.01% | 3125 |
|
|
2024
Q2 | $164K | Buy |
119,522
+10,936
| +10% | +$15K | ﹤0.01% | 2533 |
|
|
2024
Q1 | $407K | Buy |
108,586
+4,443
| +4% | +$16.7K | ﹤0.01% | 2264 |
|
|
2023
Q4 | $1.02M | Buy |
104,143
+9,998
| +11% | +$98.1K | ﹤0.01% | 1959 |
|
|
2023
Q3 | $786K | Buy |
94,145
+93,327
| +11,409% | +$779K | ﹤0.01% | 2045 |
|
|
2023
Q2 | $10.9K | Hold |
818
| – | – | ﹤0.01% | 2951 |
|
|
2023
Q1 | $9.47K | Buy |
+818
| New | +$9.47K | ﹤0.01% | 2891 |
|
|
2022
Q2 | – | Sell |
-793
| Closed | -$7K | – | 2949 |
|
|
2022
Q1 | $7K | Sell |
793
-98,099
| -99% | -$866K | ﹤0.01% | 2723 |
|
|
2021
Q4 | $2.02M | Sell |
98,892
-3,345
| -3% | -$68.4K | ﹤0.01% | 1796 |
|
|
2021
Q3 | $2.61M | Sell |
102,237
-22,913
| -18% | -$585K | ﹤0.01% | 1672 |
|
|
2021
Q2 | $4.37M | Sell |
125,150
-285,697
| -70% | -$9.99M | 0.01% | 1439 |
|
|
2021
Q1 | $13.7M | Buy |
410,847
+81,859
| +25% | +$2.73M | 0.02% | 776 |
|
|
2020
Q4 | $8.53M | Buy |
+328,988
| New | +$8.53M | 0.02% | 942 |
|
|
2020
Q3 | – | Sell |
-7,859
| Closed | -$27K | – | 3232 |
|
|
2020
Q2 | $27K | Buy |
+7,859
| New | +$27K | ﹤0.01% | 3033 |
|
|
2017
Q1 | – | Sell |
-407,395
| Closed | -$1.56M | – | 3050 |
|
|
2016
Q4 | $1.56M | Buy |
+407,395
| New | +$1.56M | ﹤0.01% | 1942 |
|